Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
February 23, 2023 17:20 ET
|
Enliven Therapeutics, Inc.
Combined company will be focused on advancing Enliven’s clinical-stage pipeline of precision oncology programs Shares to trade on Nasdaq under the new ticker symbol “ELVN” on February 24, 2023 ...